Remember the big Ebola concerns about a year ago? We just had to be careful to avoid direct contact with body fluids and we wouldn’t get infected, right? Everyone knew that even though some people were saying there was evidence it could be airborne. But the airborne hypothesis was mostly dismissed.
Good news and bad news just came out. There is a vaccine which is working in the first primate trials. Inhalable Ebola vaccine effective in primates:
One dose of an inhalable Ebola vaccine was enough to protect monkeys exposed to 1,000 times the fatal Ebola dose from being infected by the disease, according to a new study.
An inhalable version of the vaccine means that highly trained medical personnel would not be necessary to distribute it, however researchers remain cautious because one vaccine this year already was shown to have no effect on humans despite working well in primates.
Researchers compared the effects of the aerosol and liquid forms as well, finding that the aerosol appeared to induce a stronger immune response in the respiratory tract than the liquid form. Because Ebola, which can be spread through the air, often enters the body through the lungs and respiratory system, the extra protection from the virus there is seen as important to its efficacy.